Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas. It also provides non-prescription products for cough, cold, cerebral, peripheral circulation, gastrointestinal tract, metabolism, and other therapeutic areas, as well as analgesics, vitamins, minerals, and vasoprotectives. In addition, the company offers animal health products, including antiparasitics, antimicrobials, and other products. Further, it provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Krka Tovarna Zdravil D.D. stocks are traded under the ticker KRKAF.
What is Krka Tovarna Zdravil D.D. revenue for the last year?▼
Krka Tovarna Zdravil D.D. revenue for the last year amounts to 1.96B USD.
What is Krka Tovarna Zdravil D.D. net income for the last year?▼
KRKAF net income for the last year is 341.29M USD.
Does Krka Tovarna Zdravil D.D. pay dividends?▼
Yes, KRKAF dividends are paid annual. The last dividend per share was 8.18 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Krka Tovarna Zdravil D.D. located?▼
Krka Tovarna Zdravil D.D. operates in the Technology sector.
When did Krka Tovarna Zdravil D.D. complete a stock split?▼
Krka Tovarna Zdravil D.D. has not had any recent stock splits.
Where is Krka Tovarna Zdravil D.D. headquartered?▼
Krka Tovarna Zdravil D.D. is headquartered in Smarjeska Cesta 6, Other.